Heart Disease News and Research

Latest Heart Disease News and Research

POZEN reports net loss of $6.9M for year ended December 31, 2009

POZEN Inc., today announced results for the fourth quarter and year ended December 31, 2009.

3 Mar 2010

Major sports arenas in Europe have no adequate equipment, procedures to save spectators who suffer heart attacks

Too many major sports arenas in Europe do not have adequate equipment and procedures in place to save the lives of spectators who suffer heart attacks while watching a sporting event, according to new research published online today (Wednesday 3 March) in the European Heart Journal.

3 Mar 2010

Positive clinical trial results of EndoBarrier Gastrointestinal Liner device announced

GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced initial, positive results from a clinical trial evaluating 12 months of treatment with the EndoBarrier™ Gastrointestinal Liner.

3 Mar 2010

Report provides comprehensive insight into how physicians classify and treat patients with gout

BioTrends Research Group, Inc. is pleased to announce the availability of its TreatmentTrends®: Gout and Hyperuricemia publication. The report is based on responses to online surveys completed by 120 Rheumatologists and 57 Primary Care Physicians in the US who are managing a high number of patients with gout.

3 Mar 2010

FDA releases key findings of nation's dietary habits in Health and Diet Survey

More than half of consumers in the United States often read the food label when buying a product for the first time. These consumers are also increasingly aware of the link between diet and heart disease.

3 Mar 2010

Children’s Mercy Hospitals and Clinics installs Infinix CF-i/BP vascular X-ray systems

To bring the latest in cardiovascular X-ray technology to its pediatric patients, Children’s Mercy Hospitals and Clinics in Kansas City, Mo., has installed two InfinixTM CF-i/BP vascular X-ray systems with 8" x 8" flat panel detectors (FPD) from Toshiba America Medical Systems, Inc. These systems are the first pediatric bi-plane systems in the U.S. equipped with Toshiba’s Next Generation Advanced Image Processing (AIP) capabilities.

3 Mar 2010

Step-up treatments may benefit children with asthma on low-dose inhaled corticosteroids

Children with asthma who continue to have symptoms while using low-dose inhaled corticosteroids could benefit from increasing the dosage or adding one of two asthma drugs, a new study by researchers at Washington University School of Medicine and other institutions finds.

3 Mar 2010

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

Data from two Phase III studies of Merck’s investigational fixed-dose combinations of mometasone furoate and formoterol fumarate (MF/F) were presented by researchers today in two poster presentations at the American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting.

3 Mar 2010

Merck announces updated late-stage pipeline following its recent merger with Schering-Plough

Merck & Co., Inc. today announced its updated, newly integrated, late-stage pipeline following its recent merger with Schering-Plough. The new pipeline features a broad and diversified portfolio of investigational medicines and vaccines, including more than 20 candidates in Phase III or under regulatory review, and more than 20 candidates in Phase II of development.

3 Mar 2010

RMR can non-invasively, quickly and accurately detect presence of sCAD

Newly published data shows using a Respiratory Modulation Response (RMR) is a novel, non-invasive measure to quickly and accurately detect the presence of significant coronary artery disease (sCAD). Patients in the study with sCAD had a lower RMR compared to patients without, regardless of their risk factors or clinical history of angina, previous myocardial infarction (MI), or angioplasty.

3 Mar 2010

Acuo Technologies granted patent covering technology implemented in DSG software suite

Acuo Technologies, the market leading Vendor Neutral Archive supplier, was granted US patent number 7,640,171 by the USPTO which covers technology implemented in its DICOM Services Grid™ software suite.

3 Mar 2010

Toxins in K2: Saint Louis University professor warns parents to lookout for warning signs

In the last month, Anthony Scalzo, M.D., professor of toxicology at Saint Louis University, has seen nearly 30 cases involving teenagers who were experiencing hallucinations, severe agitation, elevated heart rate and blood pressure, vomiting and, in some cases, tremors and seizures. All of these teens had smoked a dangerous, yet legal substance known as K2 or "fake weed."

3 Mar 2010

Greater use of ESAs and iron at lower hematocrit levels decrease risk of death for hemodialysis patients

Greater use of erythropoiesis-stimulating agents (ESAs) and more frequent use of iron at lower hematocrit levels (the proportion of the blood that consists of red blood cells) was associated with a decreased risk of death for hemodialysis patients, according to a study in the March 3 issue of JAMA.

3 Mar 2010

Aggressive treatment of anemia with ESAs may lower risk of death for dialysis patients: Study

Aggressive treatment of anemia with intravenous iron and drugs known as erythropoiesis-stimulating agents (ESAs) may lower the risk of death for dialysis patients with severe anemia - but also may increase the risk of death among patients with milder anemia, a new study led by a University of North Carolina at Chapel Hill epidemiologist suggests.

3 Mar 2010

Axiogenesis, Lonza Cologne announce global distribution agreement

Axiogenesis AG has entered into a worldwide, exclusive distribution agreement with Lonza Cologne AG effective 01 January 2010. The agreement includes Axiogenesis’s current product and service portfolio, including the industry standard Cor.At® mouse embryonic stem cell-derived cardiomyocytes.

3 Mar 2010

Junk food consumption on the rise among U. S. children

Children in the United States are snacking more than ever before on salty chips, candy and other junk food, according to a new University of North Carolina at Chapel Hill study.

3 Mar 2010

Nemours: New efforts to reduce prevalence of overweight and obesity among Delaware's children

The prevalence of overweight and obesity among Delaware children, ages 2-17, shows a flattening of the trajectory – no change- between 2006 and 2008. Because overweight and obesity rates had previously been climbing rapidly, the leveling-off is cause for optimism reports Nemours in the March 2010 edition of Health Affairs, a peer-reviewed publication and the country's most respected health policy journal.

3 Mar 2010

Baxter Healthcare's IIPV product recall of HomeChoice peritoneal dialysis cyclers classified as Class I recall

Baxter Healthcare Corporation announced today that the U.S. Food and Drug Administration (FDA) has classified Baxter’s recent Urgent Product Recall regarding Increased Intraperitoneal Volume (IIPV), or overfill of the abdominal cavity, associated with HomeChoice and HomeChoice Pro peritoneal dialysis cyclers as a Class I recall.

From Baxter International Inc. 3 Mar 2010

Lotus Pharmaceuticals adds five new prescription drugs to its products

Lotus Pharmaceuticals, Inc., a growing developer and producer of prescription drugs and licensed national seller of pharmaceutical products in the People's Republic of China ("PRC"), today reported that it had added five new prescription drugs to its products delivered through its national sales channels.

3 Mar 2010

Exercising during weight regain can help improve metabolic health and disease risk

With the obesity rate rising for American adults and children, health concerns such as diabetes and cardiovascular disease are a frequent reality. Although obesity itself is a major risk factor for disease, most of the threat may be associated with a cluster of risk factors called the metabolic syndrome (MetS). Losing weight can improve health and reduce these risk factors, but many people have difficulty keeping the weight off.

3 Mar 2010

Heart Disease News and Research

Latest Heart Disease News and Research

POZEN reports net loss of $6.9M for year ended December 31, 2009

Major sports arenas in Europe have no adequate equipment, procedures to save spectators who suffer heart attacks

Positive clinical trial results of EndoBarrier Gastrointestinal Liner device announced

Report provides comprehensive insight into how physicians classify and treat patients with gout

FDA releases key findings of nation's dietary habits in Health and Diet Survey

Children’s Mercy Hospitals and Clinics installs Infinix CF-i/BP vascular X-ray systems

Step-up treatments may benefit children with asthma on low-dose inhaled corticosteroids

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

Merck announces updated late-stage pipeline following its recent merger with Schering-Plough

RMR can non-invasively, quickly and accurately detect presence of sCAD

Acuo Technologies granted patent covering technology implemented in DSG software suite

Toxins in K2: Saint Louis University professor warns parents to lookout for warning signs

Greater use of ESAs and iron at lower hematocrit levels decrease risk of death for hemodialysis patients

Aggressive treatment of anemia with ESAs may lower risk of death for dialysis patients: Study

Axiogenesis, Lonza Cologne announce global distribution agreement

Junk food consumption on the rise among U. S. children

Nemours: New efforts to reduce prevalence of overweight and obesity among Delaware's children

Baxter Healthcare's IIPV product recall of HomeChoice peritoneal dialysis cyclers classified as Class I recall

Lotus Pharmaceuticals adds five new prescription drugs to its products

Exercising during weight regain can help improve metabolic health and disease risk

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Heart Disease News and Research

Latest Heart Disease News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Newsletters you may be interested in